NASDAQ·US·Drug Manufacturers - Specialty & Generic
ZTSZTS
0คะแนน
สรุป
ปานกลาง
ความมั่นใจ 89%
$113.83—
Today's session
Upside?
-1.5%
FV $112.11
P/E (TTM)?
18.9
Earnings yield
FCF yield?
3.7%
Mcap $48.05B
ขาย
Fundamental neutral·Technical sell
What investors notice
Key signs
Plain-language read of the metrics that matter most for this stock.
Strongly positive
7 · 1 · 1
Strengths
- Best-in-class return on equity57%
- High return on invested capital27%
- Gross margin trending up
- Strong free-cash-flow compounding20%
- Pristine fundamentals (Piotroski 7+)7/9
- ROIC well above cost of capital — value-creating19%
- Analyst consensus heavily Buy-skewed
Risks
- Inconsistent profitability4/10
Watchlist
- Long-term debt rising — monitor leverage
$113.83-25.6%
1Y · period change vs 2025-04-29
Score history (10y)
How quality has trended through cycles.
Verdict bands: 85+ Wonderful · 70 Solid · 55 Average · 40 Risky.
Fair value range
5 of 5 models · trimmed-mean consensus
Consensus FV
$112.11
Upside
-1.5%
Now $113.83
Our FV$112.11
Price$113.83
$2.55$218.58
Open the Fair Value tab to tweak WACC and growth, and to see all five model outputs side-by-side.
10-year financials
Annual revenue, profit, and free cash flow with year-over-year growth overlay.
YoY growth overlaid
Snapshot
At a glance
Top-line figures most investors check first.
Market cap
$48.05B
P/E (TTM)?
18.9
FCF yield?
3.7%
Dividend
$2.00
1.8% yield
52w range
$112.86 – $167.69
Score confidence
89%
Data completeness
Last updated 4/30/2026, 4:19:51 AM · Data via Yahoo Finance, FMP, EDGAR. Disclaimer